Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.

Saved in:
Bibliographic Details
Title: Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
Authors: Spring LM; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA., Han H; Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA., Liu MC; Mayo Clinic, Rochester, MN, USA., Hamilton E; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA., Irie H; Icahn School of Medicine at Mount Sinai, New York, NY, USA., Santa-Maria CA; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA., Reeves J; Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA., Pan P; GSK, Waltham, MA, USA.; EQRx, Cambridge, MA, USA., Shan M; GSK, Waltham, MA, USA.; Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA., Tang Y; GSK, Waltham, MA, USA., Graham JR; GSK, Waltham, MA, USA.; Alkermes Incorporated, Waltham, MA, USA., Hazard S; GSK, Waltham, MA, USA.; Bicycle Therapeutics, Boston, MA, USA., Ellisen LW; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA., Isakoff SJ; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu.
Source: Nature cancer [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138.
Publication Type: Published Erratum
Journal Info: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 101761119 Publication Model: Print Cited Medium: Internet ISSN: 2662-1347 (Electronic) Linking ISSN: 26621347 NLM ISO Abbreviation: Nat Cancer Subsets: MEDLINE; PubMed not MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 35931884
AccessLevel: 2
PubTypeId: unknown
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Spring+LM%22">Spring LM</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Han+H%22">Han H</searchLink>; Moffitt Cancer Center-McKinley Outpatient Clinic, Tampa, FL, USA.<br /><searchLink fieldCode="AU" term="%22Liu+MC%22">Liu MC</searchLink>; Mayo Clinic, Rochester, MN, USA.<br /><searchLink fieldCode="AU" term="%22Hamilton+E%22">Hamilton E</searchLink>; Sarah Cannon Research Institute/Tennessee Oncology, Nashville, TN, USA.<br /><searchLink fieldCode="AU" term="%22Irie+H%22">Irie H</searchLink>; Icahn School of Medicine at Mount Sinai, New York, NY, USA.<br /><searchLink fieldCode="AU" term="%22Santa-Maria+CA%22">Santa-Maria CA</searchLink>; Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD, USA.<br /><searchLink fieldCode="AU" term="%22Reeves+J%22">Reeves J</searchLink>; Florida Cancer Specialists-South/Sarah Cannon Research Institute, Fort Myers, FL, USA.<br /><searchLink fieldCode="AU" term="%22Pan+P%22">Pan P</searchLink>; GSK, Waltham, MA, USA.; EQRx, Cambridge, MA, USA.<br /><searchLink fieldCode="AU" term="%22Shan+M%22">Shan M</searchLink>; GSK, Waltham, MA, USA.; Translational Discovery & Development, Boston Pharmaceuticals, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Tang+Y%22">Tang Y</searchLink>; GSK, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Graham+JR%22">Graham JR</searchLink>; GSK, Waltham, MA, USA.; Alkermes Incorporated, Waltham, MA, USA.<br /><searchLink fieldCode="AU" term="%22Hazard+S%22">Hazard S</searchLink>; GSK, Waltham, MA, USA.; Bicycle Therapeutics, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Ellisen+LW%22">Ellisen LW</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.; Ludwig Center at Harvard, Boston, MA, USA.<br /><searchLink fieldCode="AU" term="%22Isakoff+SJ%22">Isakoff SJ</searchLink>; Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA. SISAKOFF@mgh.harvard.edu.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101761119%22">Nature cancer</searchLink> [Nat Cancer] 2022 Sep; Vol. 3 (9), pp. 1138.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Published Erratum
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Nature+Publishing+Group%22">Nature Publishing Group </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101761119 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2662-1347 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2226621347%22">26621347 </searchLink><i>NLM ISO Abbreviation: </i>Nat Cancer <i>Subsets: </i>MEDLINE; PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=35931884
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1038/s43018-022-00430-w
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 1138
    Titles:
      – TitleFull: Author Correction: Neoadjuvant study of niraparib in patients with HER2-negative, BRCA-mutated, resectable breast cancer.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Spring LM
      – PersonEntity:
          Name:
            NameFull: Han H
      – PersonEntity:
          Name:
            NameFull: Liu MC
      – PersonEntity:
          Name:
            NameFull: Hamilton E
      – PersonEntity:
          Name:
            NameFull: Irie H
      – PersonEntity:
          Name:
            NameFull: Santa-Maria CA
      – PersonEntity:
          Name:
            NameFull: Reeves J
      – PersonEntity:
          Name:
            NameFull: Pan P
      – PersonEntity:
          Name:
            NameFull: Shan M
      – PersonEntity:
          Name:
            NameFull: Tang Y
      – PersonEntity:
          Name:
            NameFull: Graham JR
      – PersonEntity:
          Name:
            NameFull: Hazard S
      – PersonEntity:
          Name:
            NameFull: Ellisen LW
      – PersonEntity:
          Name:
            NameFull: Isakoff SJ
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 09
              Text: 2022 Sep
              Type: published
              Y: 2022
          Identifiers:
            – Type: issn-electronic
              Value: 2662-1347
          Numbering:
            – Type: volume
              Value: 3
            – Type: issue
              Value: 9
          Titles:
            – TitleFull: Nature cancer
              Type: main
ResultId 1